Neuroimaging evidence of altered fronto-cortical and striatal function after prolonged cocaine self-administration in the rat

Neuropsychopharmacology

Volumn 36, Issue 12, 2011, Pages 2431-2440

  Gozzi, Alessandro ^a,b   Tessari, Michela ^b   Dacome, Lisa ^b   Agosta, Federica ^b   Lepore, Stefano ^b   Lanzoni, Anna ^b   Cristofori, Patrizia ^c   Pich, Emilio M ^b   Corsi, Mauro ^b   Bifone, Angelo ^a,b  

^a CENTER FOR NANOTECHNOLOGY INNOVATION NEST   (Italy)

^b GSK   (Italy)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

addiction; cocaine; dopamine; fMRI; phMRI; rat

Indexed keywords

AMPHETAMINE; COCAINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL METABOLIC RATE; BRAIN BLOOD VOLUME; BRAIN FUNCTION; BRAIN MAPPING; BRAIN REGION; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; EVOKED CORTICAL RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HISTOPATHOLOGY; MALE; MICROVASCULARIZATION; NEUROBIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; THALAMUS;

ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; CORPUS STRIATUM; FRONTAL LOBE; MAGNETIC RESONANCE IMAGING; MALE; NEURAL PATHWAYS; NEUROIMAGING; RATS; SELF ADMINISTRATION; TIME FACTORS;

EID: 80054765904     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.129     Document Type: Article

References (87)

1. Ahmed SH (2010). Validation crisis in animal models of drug addiction: Beyond non-disordered drug use toward drug addiction. Neurosci Biobehav Rev 35: 172-184.
2. Ahmed SH, Koob GF (1998). Transition from moderate to excessive drug intake: Change in hedonic set point. Science 282: 298-300. (Pubitemid 28487203)
3. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders (4th edn, revised). American Psychiatric Association: Washington, DC.
4. Barroso-Moguel R, Mendez-Armenta M, Villeda-Hernandez J, Nava-Ruiz C, Santamaria A (2002). Brain lesions induced by chronic cocaine administration to rats. Prog Neuropsychopharmacol Biol Psychiatry 26: 59-63. (Pubitemid 34045147)
5. Baumann MH, Rothman RB (1998). Alterations in serotonergic responsiveness during cocaine withdrawal in rats: Similarities to major depression in humans. Biol Psychiatry 44: 578-591. (Pubitemid 28496685)
6. Bifone A, Gozzi A (2010). Functional and pharmacological MRI in understanding brain function In: Hagan J (ed). Molecular and Functional Models in Neuropsychiatry. Springer.
7. Bjorklund LM, Saínchez-Pernaute R, Chung S, Andersson T, Chen IYC, McNaught KS et al. (2002). Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 99: 2344-2349. (Pubitemid 34169063)
8. Briand LA, Flagel SB, Garcia-Fuster MJ, Watson SJ, Akil H, Sarter M et al. (2008). Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine. Neuropsychopharmacology 33: 2969-2980.
9. Chen YC, Galpern WR, Brownell AL, Matthews RT, Bogdanov M, Isacson O et al. (1997). Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data. Magn Reson Med 38: 389-398. (Pubitemid 27386336)
10. Chen Y-CI, Brownell A-L, Galpern W, Isacson O, Bogdanov M, Beal MF et al. (1999). Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioural assessment. NeuroReport 10: 2881-2886. (Pubitemid 29507746)
11. Chen Y-CI, Mandeville JB, Nguyen TV, Talele A, Cavagna F, Jenkins BG (2001). Improved mapping of pharmacologically induced neuronal activation using the IRON technique with superparamagnetic blood pool agents. J Magn Reson Imaging 14: 517-524. (Pubitemid 33029537)
12. Choi JK, Chen YI, Hamel E, Jenkins BG (2006). Brain hemodynamic changes mediated by dopamine receptors: Role of the cerebral microvasculature in dopamine-mediated neurovascular coupling. Neuroimage 30: 700-712.
13. Deroche-Gamonet V, Belin D, Piazza PV (2004). Evidence for addiction-like behavior in the rat. Science 305: 1014-1017. (Pubitemid 39071778)
14. Dixon AL, Prior M, Morris PM, Shah YB, Joseph MH, Young AMJ (2005). Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology 48: 236-245. (Pubitemid 40208259)
15. Febo M, Segarra AC, Nair G, Schmidt K, Duong TQ, Ferris CF (2005). The neural consequences of repeated cocaine exposure revealed by functional MRI in awake rats. Neuropsychopharmacology 30: 936-943. (Pubitemid 40570909)
16. Ferrario CR, Gorny G, Crombag HS, Li Y, Kolb B, Robinson TE (2005). Neural and behavioral plasticity associated with the transition from controlled to escalated cocaine use. Biol Psychiatry 58: 751-759. (Pubitemid 41547244)
17. Gaisler-Salomon I, Schobel SA, Small SA, Rayport S (2009). How high-resolution basal-state functional imaging can guide the development of new pharmacotherapies for schizophrenia. Schizophr Bull 35: 1037-1044.
18. Gawin FH, Ellinwood EH (1988). Cocaine and other stimulants. N Engl J Med 318: 1173-1182.
19. George O, Mandyam CD, Wee S, Koob GF (2007). Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments. Neuropsychopharmacology 33: 2474-2482.
20. Goldstein RZ, Woicik PA, Maloney T, Tomasi D, Alia-Klein N, Shan J et al. (2010). Oral methylphenidate normalizes cingulate activity in cocaine addiction during a salient cognitive task. Proc Natl Acad Sci USA 107: 16667-16672.
21. Gonzalez RG, Fischman AJ, Guimaraes AR, Carr CA, Stern CE, Halpern EF et al. (1995). Functional MR in the evaluation of dementia: Correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18. AJNR Am J Neuroradiol 16: 1763-1770.
22. Gozzi A, Ceolin L, Schwarz A, Reese T, Bertani S, Bifone A (2007). A multimodality investigation of cerebral haemodynamics and autoregulation in phMRI. Magn Reson Imaging 25: 826-833. (Pubitemid 47081368)
23. Gozzi A, Crestan V, Turrini G, Clemens M, Bifone A (2010). Antagonism at serotonin 5HT2a receptors modulates functional activity of fronto-hippocampal circuit. Psychopharmacology 209: 37-50.
24. Gozzi A, Large C, Schwarz A, Bertani S, Crestan V, Bifone A (2008). Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine. Neuropsychopharmacology 33: 1690-1703. (Pubitemid 351684709)
25. Gozzi A, Massagrande M, Amantini D, Antolini M, Martinelli P, Cesari N et al. (2011). Functional magnetic resonance imaging reveals different neural substrates for the effects of orexin-1 and orexin-2 receptor antagonists. PLoS ONE 6: E16406.
26. Gu H, Salmeron BJ, Ross TJ, Geng X, Zhan W, Stein EA et al. (2010). Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity. Neuroimage 53: 593-601.
27. Harris G, Aston-Jones G (1993). Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine-and morphinedependent rats. Psychopharmacology 113: 131-136. (Pubitemid 23341057)
28. Hong LE, Hodgkinson CA, Yang Y, Sampath H, Ross TJ, Buchholz B et al. (2010). A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction. Proc Natl Acad Sci USA 107: 13509-13514.
29. Huettel S, Song AW, McCarthy G (2004). Functional Magnetic Resonance Imaging. Sinauer: Sunderland.
30. Hyder F, Kida I, Behar KL, Kennan RP, Maciejewski PK, Rothman DL (2001). Quantitative functional imaging of the brain: Towards mapping neuronal activity by BOLD fMRI. NMR Biomed 14: 413-431. (Pubitemid 33150230)
31. Jones MW, Kilpatrick IC, Phillipson OT (1988). Dopamine function in the prefrontal cortex of the rat is sensitive to a reduction of tonic GABA-mediated inhibition in the thalamic mediodorsal nucleus. Exp Brain Res 69: 623-634. (Pubitemid 18080294)
32. Kalivas PW (2004). Glutamate systems in cocaine addiction. Curr Opin Pharmacol 4: 23-29. (Pubitemid 38145834)
33. Kalivas PW, Volkow N, Seamans J (2005). Unmanageable motivation in addiction: A pathology in prefrontal-accumbens glutamate transmission. Neuron 45: 647-650. (Pubitemid 40320699)
34. Knutson B, Gibbs S (2007). Linking nucleus accumbens dopamine and blood oxygenation. Psychopharmacology 191: 813-822. (Pubitemid 46355904)
35. Koob GF, Sanna PP, Bloom FE (1998). Neuroscience of addiction. Neuron 21: 467-476. (Pubitemid 28475499)
36. Koob GF, Volkow ND (2010). Neurocircuitry of addiction. Neuropsychopharmacology 35: 217-238.
37. London ED, Bonson KR, Ernst M, Grant S (1999). Brain imaging studies of cocaine abuse: Implications for medication development. Crit Rev Neurobiol 13: 227-242. (Pubitemid 30265250)
38. Lu L, Grimm JW, Hope BT, Shaham Y (2004). Incubation of cocaine craving after withdrawal: A review of preclinical data. Neuropharmacology 47: 214-226. (Pubitemid 39298266)
39. Malin DH, Moon WD, Moy ET, Jennings RE, Moy DM, Warner RL et al. (2000). A rodent model of cocaine abstinence syndrome. Pharmacol Biochem Behav 66: 323-328. (Pubitemid 30394618)
40. Mandeville JB, Marota JJA, Kosofsky BE, Keltner JR, Weissleder R, Rosen B et al. (1998). Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn Reson Med 39: 615-624. (Pubitemid 28150996)
41. Mantsch JR, Yuferov V, Mathieu-Kia AM, Ho A, Kreek MJ (2004). Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats. Psychopharmacology 175: 26-36. (Pubitemid 39215527)
42. Markou A, Koob GF (1992). Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal. Neuropsychopharmacology 7: 213-224.
43. Martinez D, Broft A, Foltin RW, Slifstein M, Hwang DR, Huang Y et al. (2004). Cocaine dependence and D2 receptor availability in the functional subdivisions of the striatum: Relationship with cocaine-seeking behavior. Neuropsychopharmacology 29: 1190-1202. (Pubitemid 38670055)
44. Martinez D, Greene K, Broft A, Kumar D, Liu F, Narendran R et al. (2009). Lower level of endogenous dopamine in patients with cocaine dependence: Findings from PET imaging of D2/D3 receptors following acute dopamine depletion. Am J Psychiatry 166: 1170-1177.
45. McCormick DA, Wang Z (1991). Serotonin and noradrenaline excite GABAergic neurones of the guinea-pig and cat nucleus reticularis thalami. J Physiol 442: 235-255.
46. Micheli F, Bonanomi G, Blaney FE, Braggio S, Capelli AM, Checchia A et al. (2007). 1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: A series of potent and selective dopamine D(3) receptor antagonists. J Med Chem 50: 5076-5089. (Pubitemid 47585705)
47. Moretti M, Mugnaini M, Tessari M, Zoli M, Gaimarri A, Manfredi I et al. (2010). A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes. Mol Pharmacol 78: 287-296.
48. Mutschler NH, Miczek KA (1998). Withdrawal from a selfadministered or non-contingent cocaine binge: Differences in ultrasonic distress vocalizations in rats. Psychopharmacology 136: 402-408. (Pubitemid 28189671)
49. Narendran R, Martinez D (2008). Cocaine abuse and sensitization of striatal dopamine transmission: A critical review of the preclinical and clinical imaging literature. Synapse 62: 851-869.
50. Parsons LH, Koob GF, Weiss F (1995). Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther 274: 1182-1191.
51. Paterson NE, Markou A (2003). Increased motivation for self-administered cocaine after escalated cocaine intake. NeuroReport 14: 2229-2232.
52. Paxinos G (2008). The Rat Nervous System. Elsevier: London, 1193pp.
53. Peoples LL, Kravitz AV, Guillem K (2007). The role of accumbal hypoactivity in cocaine addiction. Scientific World Journal 7: 22-45. (Pubitemid 350277598)
54. Porrino LJ, Smith HR, Nader MA, Beveridge TJR (2007). The effects of cocaine: A shifting target over the course of addiction. Prog Neuropsychopharmacol Biol Psychiatry 31: 1593-1600. (Pubitemid 47625705)
55. Preece MA, Sibson NR, Raley JM, Blamire A, Styles P, Sharp T (2007). Region-specific effects of a tyrosine-free amino acid mixture on amphetamine-induced changes in BOLD fMRI signal in the rat brain. Synapse 61: 925-932. (Pubitemid 47464088)
56. Reese T, Schwarz AJ, Gozzi A, Crestan V, Bertani S, Heidbreder CA (2004). Functional magnetic resonance imaging detects spatiotemporal differences between drug-naive and amphetaminesensitised rats. Proceedings of the Twelfth ISMRM Scientific Meeting and Exhibition. ISMRM Press: Kyoto, 228 pp.
57. Ren J, Xu H, Choi JK, Jenkins BG, Chen YI (2009). Dopaminergic response to graded dopamine concentration elicited by four amphetamine doses. Synapse 63: 764-772.
58. Roberts DCS, Morgan D, Liu Y (2007). How to make a rat addicted to cocaine. Prog Neuropsychopharmacol Biol Psychiatry 31: 1614-1624. (Pubitemid 47625707)
59. Scholtz CL (1977). Quantitative histochemistry of myelin using Luxol Fast Blue MBS. Histochem J 9: 759-765. (Pubitemid 8196446)
60. Schwarz A, Gozzi A, Reese T, Bertani S, Crestan V, Hagan J et al. (2004). Selective dopamine D(3) receptor antagonist SB-277011- A potentiates phMRI response to acute amphetamine challenge in the rat brain. Synapse 54: 1-10. (Pubitemid 39129668)
61. Schwarz AJ, Danckaert A, Reese T, Gozzi A, Paxinos G, Watson C et al. (2006a). A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomicalatlas: Application to pharmacological MRI. Neuroimage 32: 538-550. (Pubitemid 44149167)
62. Schwarz AJ, Gozzi A, Reese T, Bifone A (2007a). Functional connectivity in the pharmacologically activated brain: Resolving networks of correlated responses to d-amphetamine. Magn Reson Med 57: 704-713. (Pubitemid 46731796)
63. Schwarz AJ, Gozzi A, Reese T, Bifone A (2007b). In vivo mapping of functional connectivity in neurotransmitter systems using pharmacological MRI. Neuroimage 34: 1627-1636. (Pubitemid 46187087)
64. Schwarz AJ, Reese T, Gozzi A, Bifone A (2003). Functional MRI using intravascular contrast agents: Detrending of the relative cerebrovascular (rCBV) time course. Magn Reson Imaging 21: 1191-1200. (Pubitemid 38199724)
65. Schwarz AJ, Whitcher B, Gozzi A, Reese T, Bifone A (2006b). Studylevel wavelet cluster analysis and data-driven signal models in pharmacological MRI. J Neurosci Methods 159: 346-360. (Pubitemid 44920262)
66. Sharp PM, La Regina MC (1998). The Laboratory Rat. CRC Press: Berlin, 240 pp.
67. Small SA, Chawla MK, Buonocore M, Rapp PR, Barnes CA (2004). Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging. Proc Natl Acad Sci USA 101: 7181-7186. (Pubitemid 38596463)
68. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H et al. (2004). Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1): S208-S219. (Pubitemid 39421720)
69. Strickland TL, Mena I, Villanueva-Meyer J, Miller BL, Cummings J, Mehringer CM et al. (1993). Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci 5: 419-427. (Pubitemid 23326593)
70. Tomasi D, Goldstein RZ, Telang F, Maloney T, Alia-Klein N, Caparelli EC et al. (2007). Thalamo-cortical dysfunction in cocaine abusers: Implications in attention and perception. Psychiatry Res 155: 189-201. (Pubitemid 47042365)
71. Tomasi D, Volkow ND, Wang R, Carrillo JH, Maloney T, Alia-Klein N et al. (2010). Disrupted functional connectivity with dopaminergic midbrain in cocaine abusers. PLoS ONE 5: E10815.
72. Tumeh SS, Nagel JS, English RJ, Moore M, Holman BL (1990). Cerebral abnormalities in cocaine abusers: Demonstration by SPECT perfusion brain scintigraphy. Work in progress. Radiology 176: 821-824. (Pubitemid 20266778)
73. Urbano FJ, Bisagno Vn, Wikinski SI, Uchitel OD, Llin RR (2009). Cocaine acute 'binge' administration results in altered thalamocortical interactions in mice. Biol Psychiatry 66: 769-776.
74. Vanderschuren LJMJ, Everitt BJ (2004). Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 305: 1017-1019. (Pubitemid 39071779)
75. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ et al. (1993). Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14: 169-177. (Pubitemid 23157765)
76. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F (2007). Dopamine in drug abuse and addiction: Results of imaging studies and treatment implications. Arch Neurol 64: 1575-1579. (Pubitemid 350106758)
77. Volkow ND, Fowler JS, Wolf AP, Schlyer D, Shiue CY, Alpert R et al. (1990). Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry 147: 719-724. (Pubitemid 20188509)
78. Volkow ND, Hitzemann RJ, Wang GJ, Fowler JS, Wolf AP, Dewey SL et al. (1992). Long-term frontal brain metabolic changes in cocaine abusers. Synapse 12: 86.
79. Volkow ND, Mullani N, Gould KL, Adler S, Krajewski K (1988). Cerebral blood flow in chronic cocaine users: A study with positron emission tomography. Br J Psychiatry 152: 641-648.
80. Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Gatley SJ, Dewey SS et al. (1998). Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: A PET Study. Am J Psychiatry 155: 200-206. (Pubitemid 28074281)
81. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R et al. (1997). Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386: 830-833. (Pubitemid 27181256)
82. Wee S, Specio SE, Koob GF (2007). Effects of dose and session duration on cocaine self-administration in rats. J Pharmacol Exp Ther 320: 1134-1143. (Pubitemid 46294040)
83. Wilson JM, Kish SJ (1996). The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat. J Neurosci 16: 3507-3510. (Pubitemid 26142379)
84. Wilson JM, Nobrega JN, Carroll ME, Niznik HB, Shannak K, Lac ST et al. (1994). Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self- administration. J Neurosci 14: 2966-2979. (Pubitemid 24138986)
85. Worsley KJ, Evans AC, Marrett S, Neelin P (1992). A threedimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab 12: 900-918.
86. Zaharchuk G, Mandeville JB, Bogdanov Jr AA, Weissleder R, Rosen BR, Marota JJ (1999). Cerebrovascular dynamics of autoregulation and hypoperfusion. An MRI study of CBF and changes in total and microvascular cerebral blood volume during hemorrhagic hypotension. Stroke 30: 2197-2204.
87. Zikopoulos B, Barbas H (2006). Prefrontal projections to the thalamic reticular nucleus form a unique circuit for attentional mechanisms. J Neurosci 26: 7348-7361. (Pubitemid 44315202)